ASTERA LABS INC

Astera Labs’ Nasdaq‑100 debut sparks a sharp sell‑off as investors weigh earnings volatility, memory, and AI‑stock risks, leaving the chipmaker’s share price in decline.

Astera Labs’ Nasdaq 100 debut fuels AI‑infrastructure growth. Its PCIe, CXL, and fabric solutions drive high margins, robust cash flow, and investor interest.

Astera Labs joins the Nasdaq‑100, sparking passive‑fund buying and positioning it within the fast‑growing AI & HPC sector, boosting long‑term valuation prospects.

Astera Labs joins the Nasdaq‑100, boosting liquidity and visibility for its AI‑centric connectivity solutions. Learn how the inclusion could fuel growth, impact valuation, and what investors should watch for in earnings, partnerships and market tren…

Astera Labs joins the Nasdaq‑100, boosting liquidity and investor interest while its AI‑powered interconnects promise faster, greener data‑center performance and new market growth.

Astera Labs’ June filings reveal new RSU awards for key directors, reaffirmation of board seats through its 2026 annual meeting, and a strong shareholder‑approved pay‑structure—showcasing solid governance and executive alignment in the semiconductor…

Astera Labs’ recent insider‑trading filings show disciplined, compliant equity sales that keep execs aligned with shareholders while boosting investor confidence in the semiconductor market.

Astera Labs insider trades show confidence amid node‑scale advancements—yield, EUV, and AI‑edge focus highlight the company’s tech‑strategy and market strength.

Astera Labs’ insider filings reveal a modest ESPP exercise and a planned share sale, illustrating strategic equity management and compliance in the semiconductor sector.

Astera Labs insider sale: 50,000 shares sold by former officer Michael Tate, unlikely to impact price or liquidity—key takeaways for IT buyers.